Purchases and Sales Made in Q4 2024 in Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX) during Q4 2024. The information is specifically focused on institutions that hold shares of Amylyx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-397K- 12.85% |
$1.17M - $2.79M
|
2.69M
$17M
|
|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-461K- 70.98% |
$1.35M - $3.24M
|
188K
$1.19M
|
|
|
Feb 13, 2025
Q4 2024
|
Alpha Wave Global, LP
New York, NY |
SELL
|
- |
-521K- 77.8% |
$1.53M - $3.66M
|
149K
$936K
|
|
|
Feb 11, 2025
Q4 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-1.16M- 65.43% |
$3.41M - $8.14M
|
612K
$3.86M
|
|
|
Feb 14, 2025
Q4 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-1.2M- 59.31% |
$3.53M - $8.44M
|
823K
$5.19M
|